IS5534A - Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum - Google Patents

Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum

Info

Publication number
IS5534A
IS5534A IS5534A IS5534A IS5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A
Authority
IS
Iceland
Prior art keywords
headache
local anesthetic
new use
anesthetic agents
agents
Prior art date
Application number
IS5534A
Other languages
English (en)
Inventor
Dalsgaard Carl-Johan
Eek Arne
Waldenlind Lennart
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5534A publication Critical patent/IS5534A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5534A 1997-12-19 2000-06-15 Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum IS5534A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (sv) 1997-12-19 1997-12-19 New use
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (1)

Publication Number Publication Date
IS5534A true IS5534A (is) 2000-06-15

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5534A IS5534A (is) 1997-12-19 2000-06-15 Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum

Country Status (18)

Country Link
EP (1) EP1047412A1 (is)
JP (1) JP2001526217A (is)
KR (1) KR20010024768A (is)
CN (1) CN1282241A (is)
AU (1) AU1898199A (is)
BR (1) BR9813775A (is)
CA (1) CA2314452A1 (is)
EE (1) EE200000394A (is)
HU (1) HUP0100599A3 (is)
ID (1) ID26703A (is)
IL (1) IL136518A0 (is)
IS (1) IS5534A (is)
NO (1) NO20003138L (is)
PL (1) PL341283A1 (is)
SE (1) SE9704770D0 (is)
SK (1) SK7832000A3 (is)
TR (1) TR200001926T2 (is)
WO (1) WO1999032103A1 (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
AU2862200A (en) 1999-01-27 2000-08-18 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
MX378344B (es) 2014-03-21 2025-03-10 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
JP2018532728A (ja) * 2015-09-24 2018-11-08 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー （持続性）外傷後頭痛の予防、治療および低減
SMT202600087T1 (it) 2016-09-23 2026-03-09 Teva Pharmaceuticals Int Gmbh Trattamento dell’emicrania refrattaria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
JP2001526217A (ja) 2001-12-18
AU1898199A (en) 1999-07-12
BR9813775A (pt) 2000-10-10
PL341283A1 (en) 2001-04-09
SK7832000A3 (en) 2001-02-12
EP1047412A1 (en) 2000-11-02
HUP0100599A3 (en) 2002-04-29
WO1999032103A1 (en) 1999-07-01
ID26703A (id) 2001-02-01
TR200001926T2 (tr) 2000-11-21
CA2314452A1 (en) 1999-07-01
EE200000394A (et) 2001-12-17
KR20010024768A (ko) 2001-03-26
NO20003138L (no) 2000-08-18
SE9704770D0 (sv) 1997-12-19
IL136518A0 (en) 2001-06-14
HUP0100599A2 (hu) 2002-02-28
NO20003138D0 (no) 2000-06-16
CN1282241A (zh) 2001-01-31

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
NO993068L (no) Ny forbindelsesform
FI971412L (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
NO992806L (no) Terapeutiske midler
DE69534990D1 (de) Kontrastmittel
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
FI964318A7 (fi) Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita
ID18679A (id) Penggunaan terapi lanjutan
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
NO993298D0 (no) Ny fremgangsmÕte
FI965197L (fi) Leukotriaryylimetaanien käyttö hiilivetyjen merkitsemiseen
EE04439B1 (et) 5HT1 antagonistid antidepressantraviks
NO995796D0 (no) Ny fremgangsmåte
EE9600127A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
EE9600160A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
ID26703A (id) Penggunaan anestesi lokal untuk sakit kepala vaskular
IS5814A (is) Ný lyfjafræðileg notkun á NOS lötum
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
IS4320A (is) Ný súbstitúeruð bensimidasól
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
FI974235A0 (fi) Ny bestaemningsmetod
FI971253L (fi) Lyoluminesenssin käyttö analyyttisiin tarkoituksiin
SE9702595D0 (sv) new therapeutic use
BR1101089A (pt) Composição terapêutica de uso nasal